22-Aug-2007 - Pfizer announced today it is breaking ground on a $50m expansion of its biologics pilot plant in Chesterfield in a move that comes at time when the drug giant is cutting back in other business areas.
21-Aug-2007 - Solvay Pharmaceuticals still believed it was on track for meeting US regulatory deadlines for pancreatic insufficiency drugs despite receiving an approvable letter for its own newly formulated drug Creon.
21-Aug-2007 - Swiss firm Novartis has gained US approval of its once-yearly treatment for postmenopausal osteoporosis, with EU approval expected to follow hot on its heels.
16-Aug-2007 - Danish diabetes care specialist Novo Nordisk has expanded an agreement with biotech supplier Millipore, granting exclusive, long-term distribution rights to the company's insulin products for cell culture applications.
14-Aug-2007 - A Canadian firm that has developed a technology to double the amount of flu virus obtained during traditional egg-based vaccine production is launching a dedicated team to help manufacturers implement the platform and ramp up their production capabilities.
14-Aug-2007 - The US launch of the hotly touted, next-generation mouthwash, Decapinol, has stalled following the decision to reformulate the US product as a "precautionary measure".
13-Aug-2007 - UK Hikma Pharmaceuticals has acquired Egyptian pharmaceutical company Alkan Pharma in a deal worth $60.5m (€44.2m), and establishes the London-based company in the Egyptian market.
13-Aug-2007 - The lowest formulated dose of cholesterol-busting fenofibrate has been approved for the US market using a new formulation platform.
09-Aug-2007 - Two US life sciences companies have been awarded contracts from the National Institutes of Allergy and Infectious Diseases (NIAID) to develop vaccines.
09-Aug-2007 - GlaxoSmithKline (GSK) has suffered a blow in the advance of its top selling pharma drug Advair after US regulators issued a not approvable letter for an increased strength in the treatment of chronic obstructive pulmonary disease.
07-Aug-2007 - GlaxoSmithKline (GSK) is bolstering its pandemic H5N1 vaccine presence in the US after being awarded a contract to provide 22.5 million doses of bulk antigen to the US stockpile while launching clinical trials for its adjuvanted H5N1 vaccine.
07-Aug-2007 - An improved inhalable insulin product developed by collaborating UK and US firms has just completed a glucose clamp study in the US, with results suggesting that the product could pose a significant threat to Pfizer's Exubera franchise.
06-Aug-2007 - Japan's Chugai Pharmaceuticals is voluntarily recalling almost 2000 bottles of Vesanoid capsules (tretinoin) after the drug was found to contain unapproved bovine-derived material from Canada.
02-Aug-2007 - US firm SurModics has acquired fellow drug delivery specialist Brookwood Pharmaceuticals in a deal worth up to $62m.
02-Aug-2007 - Invitrogen has announced its second quarter financial results with the BioDiscovery business unit showing a greater than expected growth.
02-Aug-2007 - Switzerland-based Lonza is establishing its biopharma portfolio with the acquisition of Zyentia's Aggresolve technology this week.
02-Aug-2007 - Solid-dose specialist Colorcon has hooked up with materials science firm DataLase to develop a new no-touch on-tablet marking technique specifically for film-coated tablets, helping to defend branded tabs from counterfeiting attempts and protect patient safety.
01-Aug-2007 - Wyeth executives are remaining positive Pristiq (desvenlafaxine) will eventually be approved as a treatment both for depression and vasomotor symptoms associated with menopause despite recent setbacks.
01-Aug-2007 - GPC Biotech has withdrawn its hotly touted satraplatin New Drug Application (NDA) for accelerated approval following last week's less than glowing recommendation to hold off on its approval.
31-Jul-2007 - A new peelable membrane closure for heat-and-eat food is designed for convenience and to withstand thermal processing.
31-Jul-2007 - The concept of a "Super Combination Traveler's Vaccine" has come one step closer to reality with the initiation of a Phase II study on a single dose, oral typhoid fever vaccine.
30-Jul-2007 - A new booster vaccine aimed to up the immune response against tuberculosis (TB) has entered Phase II trials in South Africa.
30-Jul-2007 - A novel drug delivery technology capable of delivering large molecules in oral tablet form is set to gain patent protection in a number of countries through an international patent treaty.
26-Jul-2007 - GPC Biotech was dealt a blow this week as an advisory committee recommended that regulatory bodies should hold off on approval of a novel oral formulation of a platinum-based cancer drug.
25-Jul-2007 - Biovail has this week sought to reassure its investors after the news that US regulators issued the company with a Non Approval letter for its new bupropion salt anti-depressant.